Groowe Groowe / Newsroom / VTRS
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

VTRS News

Viatris Inc. Common Stock

Ritedose Commits to National "Hope Alliance" Campaign to Support Uninsured Patients

prnewswire.com
VTRS AMRX ARX

Treg Cell-Based Therapies Clinical Trial Pipeline Appears Robust With 29+ Key Pharma Companies Actively Working in the Domain | DelveInsight

globenewswire.com
RAPT SANG INCY ABBV ARCT AMGN CHKP PFE LLY SCLX SNY UCB BIIB NVS VTRS BMY ABSI ALEC GSK IONS CLNN ANNX MED GAM VRTX EXC BLRX

U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain

prnewswire.com
VTRS

Form 8-K

sec.gov
VTRS

U.S. FDA Approves INQOVI ® in Combination with Venetoclax, the First All-Oral Combination Treatment for Patients with Acute Myeloid Leukemia Who Are Ineligible for Intensive Induction Chemotherapy

businesswire.com
VTRS

Insulin Aspart Market Shifts Toward Access and Biosimilar Competition as Rapid-Acting Insulin Remains Essential for Mealtime Glucose Control

accessnewswire.com
NVO SNY VTRS

Viatris to Present at the Bank of America Securities 2026 Healthcare Conference

prnewswire.com
VTRS

Form 8-K

sec.gov
VTRS

Viatris Reports First-Quarter 2026 Financial Results

prnewswire.com
VTRS

American Kidney Fund and AKF Ambassadors on Capitol Hill for Annual AKF Kidney Action Summit

globenewswire.com
ALNY AMGN ARDX AZN BIIB CDTX CSL GSK NVS PFE SNY VRTX VTRS